HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Operation Wildfire

This article was originally published in The Tan Sheet

Executive Summary

Agents seized "209 pounds of methamphetamines, 201,035 tablets of pseudoephedrine, 158 kilograms of pseudoephedrine powder and 224,860 tablets of ephedrine" during "Operation Wildfire," the "largest nationally coordinated law enforcement initiative" to date, DEA announces Aug. 30. Wildfire was "designed to target all levels of the methamphetamine manufacturing and distribution chain" in the U.S. and involved authorities in more than 200 cities. Most of the pseudoephedrine was bought from "mom and pop" stores and pharmacies, and represented a combination of dosage forms, DEA said. The initiative closely follows the White House's announcement of a meth strategy that supports national pseudoephedrine purchase limits, but not behind-the-counter sale (1"The Tan Sheet," Aug. 22, 2005, p. 4)...

Agents seized "209 pounds of methamphetamines, 201,035 tablets of pseudoephedrine, 158 kilograms of pseudoephedrine powder and 224,860 tablets of ephedrine" during "Operation Wildfire," the "largest nationally coordinated law enforcement initiative" to date, DEA announces Aug. 30. Wildfire was "designed to target all levels of the methamphetamine manufacturing and distribution chain" in the U.S. and involved authorities in more than 200 cities. Most of the pseudoephedrine was bought from "mom and pop" stores and pharmacies, and represented a combination of dosage forms, DEA said. The initiative closely follows the White House's announcement of a meth strategy that supports national pseudoephedrine purchase limits, but not behind-the-counter sale (1 (Also see "White House Meth Bill Plan Would Not Put Pseudoephedrine Behind Counters" - Pink Sheet, 22 Aug, 2005.), p. 4)....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS126601

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel